Refine
Year of publication
Document Type
- Preprint (667)
- Article (442)
- Book (1)
- Conference Proceeding (1)
- Contribution to a Periodical (1)
- Review (1)
- Working Paper (1)
Has Fulltext
- yes (1114)
Is part of the Bibliography
- no (1114)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- SARS-CoV-2 (8)
- Heavy-ion collision (6)
- COVID19-NMR (5)
- ALICE experiment (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- Solution NMR spectroscopy (4)
- 5′-UTR (3)
- ALICE (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- RNA (3)
- pp collisions (3)
- ACLF (2)
- BCR/ABL (2)
- Beauty production (2)
- Charm physics (2)
- Epilepsy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Heavy Quark Production (2)
- Lepton-Nucleon Scattering (experiments) (2)
- NMR spectroscopy (2)
- Non-structural protein (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Philadelphia chromosome (2)
- QCD (2)
- Seizure (2)
- Single electrons (2)
- Solution NMR-spectroscopy (2)
- acute-on-chronic liver failure (2)
- glioblastoma (2)
- proteomics (2)
- radiotherapy (2)
- 19F (1)
- 2-deoxyglucose (2-DG) (1)
- 5'-UTR (1)
- 5_SL4 (1)
- 900 GeV (1)
- ALICE detector (1)
- ALK-rearranged NSCLC (1)
- Abl kinase inhibitors (1)
- Active middle ear implants (1)
- Allosteric inhibition (1)
- Alternating Phase Focusing (1)
- Angiomyolipoma (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Anticonvulsant (1)
- Auditory system (1)
- Autologous stem cell transplantation (1)
- B cell receptor (1)
- B. subtilis (1)
- Bartonella grahamii (1)
- Bartonella henselae (1)
- Bartonella schoenbuchensis (1)
- Beam dynamics simulation (1)
- Beskid Niski Mts (1)
- Biogeochemistry (1)
- Biomarker (1)
- Bone conduction devices (1)
- Boosted Jets (1)
- Brain tumor (1)
- Business strategy in drug development (1)
- CAKUT (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- COVID-19 (1)
- CPTAC (1)
- CRC65 (1)
- Carbon cycle (1)
- Cementation (1)
- Centrality Class (1)
- Centrality Selection (1)
- Ceramic (1)
- Chemical communication (1)
- Chocó rainforest (1)
- Chronic disease (1)
- Collective Flow, (1)
- Communication center (1)
- Comparative genomics (1)
- Comparison with QCD (1)
- Consensus statement (1)
- Continuous wave (1)
- Core marking (1)
- Costs (1)
- Covid19-NMR (1)
- Covid19-nmr (1)
- DNA-PAINT (1)
- Data sharing (1)
- Depression (1)
- Diagnostic imaging (1)
- Drug screens (1)
- Drug therapy (1)
- E. coli (1)
- Ecosystem ecology (1)
- Ecuador (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Everolimus (1)
- Evolution (1)
- FBS (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Forest ecology (1)
- Functionally-impaired elderly (1)
- Fungi (1)
- Gene expression profiling (1)
- General practice (1)
- Genetics (1)
- Glioma (1)
- HBT (1)
- HOD (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hard Scattering (1)
- Health policy (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ion (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Hematology (1)
- High-dose chemotherapy (1)
- High-throughput screening (1)
- Holmes tremor (1)
- Hyperons (1)
- Immunology (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Invertebrates (1)
- Ionisation energy loss (1)
- Ixodes ricinus (1)
- Jet Physics (1)
- Jet Substructure (1)
- Lenalidomide (1)
- Leukemias (1)
- Linear accelerator (1)
- Localized defecation (1)
- MTOR inhibitor (1)
- Macrodomain (1)
- Magnetic resonance imaging (1)
- Material budget (1)
- Meriç River (1)
- Microplastic (1)
- Mid-rapidity (1)
- Minimal invasive (1)
- Minimum Bias (1)
- Mixed hearing loss (1)
- Mixture toxicity (1)
- Molecular biology (1)
- Molecular matched therapy (1)
- Molecular medicine (1)
- Molecular modelling (1)
- Molecular profiling (1)
- Molecular therapy (1)
- Mollusks (1)
- Monolithic crown (1)
- Monte Carlo (1)
- Multi-Parton Interactions (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multiple myeloma (1)
- Multiple stressors (1)
- NAFL (1)
- NASH (1)
- Neural network (1)
- Neuroscience (1)
- Non-small cell lung cancer (1)
- Nonlinear beam dynamics (1)
- Nuclear modification factor (1)
- Nucleus (1)
- Oncology (1)
- Osimertinib (1)
- PYTHIA (1)
- Pain (1)
- Particle and Resonance Production (1)
- Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (1)
- Pb–Pb (1)
- Physiology (1)
- Plant symbiosis (1)
- Pond snail (1)
- Positron emission tomography (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Protein drugability (1)
- Proteins (1)
- Proton (1)
- Proton–proton (1)
- Psychiatric disorders (1)
- Quality of life (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- RNA genome (1)
- RNASolution-state NMR (1)
- RSL curve (1)
- Rapidity Range (1)
- Rehabilitation (1)
- Relapse (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- Rhabdomyoma (1)
- SL1 (1)
- SL5a (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- SLC20A1 (1)
- SPSS (1)
- Second-line treatment (1)
- Self-assessment (1)
- Single muons (1)
- Sociodemographic characteristics (1)
- Strangeness (1)
- Subependymal giant cell astrocytoma (1)
- Surgery (1)
- Systematic Uncertainty (1)
- TP53 mutation status (1)
- TR (1)
- TSC (1)
- Target validation (1)
- Targeted therapy (1)
- Technical data (1)
- Tet-inducible system (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Urban ecology (1)
- Vasculitis (1)
- Vector Boson Production (1)
- Warburg effect (1)
- Xenon-based gas mixture (1)
- Zirconia (1)
- aboveground biomass (1)
- accessory proteins (1)
- acute coronary syndrome (1)
- acute decompensation (1)
- acute lymphatic leukemia (1)
- adult (1)
- aegean (1)
- aging (1)
- allosteric inhibition (1)
- amplicon sequencing (1)
- antisynthetase antibodies (1)
- antisynthetase syndrome (1)
- archeological sea-level limiting points (1)
- arthritis (1)
- artifacts (1)
- artificial feeding (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- biochemistry (1)
- biodiversity (1)
- biophysics (1)
- bipartite networks (1)
- bladder exstrophy-epispadias complex (1)
- cancer (1)
- cannabidiol (1)
- cannabinoids (1)
- cannabis (1)
- cell-free protein synthesis (1)
- cerebrospinal fluid (1)
- chemotherapy (1)
- chronosequence (1)
- cirrhosis (1)
- clinical trial (1)
- cloacal malformation (1)
- coastal geomorphology (1)
- computed tomography (1)
- copeptin (1)
- dE/dx (1)
- data quality (1)
- deadwood (1)
- decomposition (1)
- detector (1)
- diffusion-weighted magnetic resonance imaging (1)
- doxycycline (1)
- drug response (1)
- dysbiosis (1)
- ectosomes (1)
- electrical resistivity tomography (1)
- electroencephalography (EEG) (1)
- exosomes (1)
- experimental results (1)
- extracellular vesicles (1)
- females (1)
- fluorine (1)
- folding (1)
- foraminifera (1)
- foraminifers (1)
- fragment screening (1)
- fragment-based screening (1)
- functional genetics (1)
- geophysical prospections (1)
- global change (1)
- glycolysis (1)
- guidelines (1)
- habitat destruction (1)
- head-and-neck cancer (1)
- healthy subjects (1)
- heavy ion experiments (1)
- hepatic encephalopathy (1)
- hypoxia-induced cell death (1)
- immunotherapy (1)
- inducible gene expression (1)
- inflammation (1)
- interferon gamma (1)
- interstitial lung disease (1)
- intrinsically disordered region (1)
- isocaloric ketogenic diet (1)
- kidney formation (1)
- kinetics (1)
- land use (1)
- lichen diversity (1)
- lichenized fungi (1)
- liver (1)
- lung cancer (1)
- mTOR inhibitor (1)
- magnetic gradiometry (1)
- magnetic resonance imaging (1)
- mechanical ventilation (1)
- medulloblastoma (1)
- medulloblastoma resection (1)
- meta-stable structures (1)
- metabolic cancer therapy (1)
- metabolic syndromes (1)
- metastasis (1)
- microbes (1)
- microbiome (1)
- micropalaeontology (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- mitochondria (1)
- model psychosis (1)
- modularity (1)
- molecular therapy (1)
- mortality (1)
- multicenter study (1)
- multiplexed immunofluorescence (1)
- myocardial infarction (1)
- myositis (1)
- myxomycete (1)
- neoadjuvant chemoradiotherapy (1)
- neoepitopes (1)
- neurodegeneration (1)
- new records (1)
- newly diagnosed glioblastoma (1)
- nivolumab (1)
- nonstructural proteins (1)
- nymphs (1)
- oral cavity cancer (1)
- palatal tremor (1)
- patient stratification (1)
- portal hypertension (1)
- portosystemic shunt (1)
- posterior fossa masses (1)
- predictive biomarker (1)
- proteins (1)
- pulmonary failure (1)
- quark gluon plasma (1)
- randomized (1)
- rare species (1)
- rct (1)
- reassembly (1)
- registry (1)
- reproducibility (1)
- resilience (1)
- resistance (1)
- respiratory failure (1)
- riboswitches (1)
- rigor (1)
- saprotrophic fungi (1)
- sea-level indicator (1)
- sequential ALK-inhibitor therapy (1)
- specialization (1)
- spectra (1)
- spontaneous portosystemic shunt (1)
- standardization (1)
- structural biology (1)
- structural proteins (1)
- subgrouping (1)
- targeted therapy (1)
- temozolomide (1)
- tetracycline (1)
- tetrahydrocannabinol (1)
- transcription (1)
- transovarial transmission (1)
- transstadial transmission (1)
- trees (1)
- troponin (1)
- tumor metabolism (1)
- tumor-infiltrating lymphocytes (1)
- unmethylated MGMT (1)
- urinary tract development (1)
- vector (1)
- zebrafish development (1)
- “gatekeeper” mutation T315I (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1031)
- Frankfurt Institute for Advanced Studies (FIAS) (954)
- Informatik (921)
- Medizin (49)
- Biowissenschaften (12)
- Biochemie, Chemie und Pharmazie (10)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (9)
- Geowissenschaften (4)
- Biodiversität und Klima Forschungszentrum (BiK-F) (3)
- Georg-Speyer-Haus (3)
Objective: The term ‘precision medicine’ describes a rational treatment strategy tailored to one person that reverses or modifies the disease pathophysiology. In epilepsy, single case and small cohort reports document nascent precision medicine strategies in specific genetic epilepsies. The aim of this multicentre observational study was to investigate the deeper complexity of precision medicine in epilepsy. Methods: A systematic survey of patients with epilepsy with a molecular genetic diagnosis was conducted in six tertiary epilepsy centres including children and adults. A standardised questionnaire was used for data collection, including genetic findings and impact on clinical and therapeutic management. Results: We included 293 patients with genetic epilepsies, 137 children and 156 adults, 162 females and 131 males. Treatment changes were undertaken because of the genetic findings in 94 patients (32%), including rational precision medicine treatment and/or a treatment change prompted by the genetic diagnosis, but not directly related to known pathophysiological mechanisms. There was a rational precision medicine treatment for 56 patients (19%), and this was tried in 33/56 (59%) and was successful (ie, >50% seizure reduction) in 10/33 (30%) patients. In 73/293 (25%) patients there was a treatment change prompted by the genetic diagnosis, but not directly related to known pathophysiological mechanisms, and this was successful in 24/73 (33%). Significance: Our survey of clinical practice in specialised epilepsy centres shows high variability of clinical outcomes following the identification of a genetic cause for an epilepsy. Meaningful change in the treatment paradigm after genetic testing is not yet possible for many people with epilepsy. This systematic survey provides an overview of the current application of precision medicine in the epilepsies, and suggests the adoption of a more considered approach.
Increasing atmospheric CO2 stimulates photosynthesis which can increase net primary production (NPP), but at longer timescales may not necessarily increase plant biomass. Here we analyse the four decade-long CO2-enrichment experiments in woody ecosystems that measured total NPP and biomass. CO2 enrichment increased biomass increment by 1.05 ± 0.26 kg C m−2 over a full decade, a 29.1 ± 11.7% stimulation of biomass gain in these early-secondary-succession temperate ecosystems. This response is predictable by combining the CO2 response of NPP (0.16 ± 0.03 kg C m−2 y−1) and the CO2-independent, linear slope between biomass increment and cumulative NPP (0.55 ± 0.17). An ensemble of terrestrial ecosystem models fail to predict both terms correctly. Allocation to wood was a driver of across-site, and across-model, response variability and together with CO2-independence of biomass retention highlights the value of understanding drivers of wood allocation under ambient conditions to correctly interpret and predict CO2 responses.
From hunting and foraging to clearing land for agriculture, humans modify forest biodiversity, landscapes, and climate. Forests constantly undergo disturbance–recovery dynamics and understanding them is a major objective of ecologists and conservationists. Chronosequences are a useful tool for understanding global restoration efforts. They represent a space-for-time substitution approach suited for the quantification of the resistance of ecosystem properties to withstand disturbance and the resilience of these properties until reaching pre-disturbance levels. Here we introduce a newly established chronosequence with 62 plots (50 ⍰ 50 m) in active cacao plantations and pastures, early and late regeneration, and mature old-growth forests, across a 200 km2 area in the extremely wet Chocó rainforest. Our chronosequence covers by far the largest total area of plots compared to others in the Neotropics. Plots ranged from 159–615 masl in a forested landscape with 74 ± 2.8 % forest cover within a 1-km radius including substantial old-growth forest cover. Land-use legacy and regeneration time were not confounded by elevation. We tested how six forest structure variables (maximum tree height and DBH, basal area, number of stems, vertical vegetation heterogeneity, and light availability), aboveground biomass (AGB), and rarefied tree species richness change along our chronosequence. Forest structure variables, AGB, and tree species richness increased with regeneration time and are predicted to reach similar levels to those in old-growth forests after ca. 30–116, 202, and 108 yrs, respectively. Compared to previous work in the Neotropics, old-growth forests in Canandé accumulate high AGB that takes one of the largest time spans reported until total recovery. Our chronosequence comprises one of the largest tree species pools, covers the largest total area of regenerating and old-growth forests, and has higher forest cover than other Neotropical chronosequences. Hence, our chronosequence can be used to determine the time for recovery and stability (resistance and resilience) of different taxa and ecosystem functions, including species interaction networks. This integrative effort will ultimately help to understand how one of the most diverse forests on the planet recovers from large-scale disturbances.
Gene-modified autologous hematopoietic stem cells (HSC) can provide ample clinical benefits to subjects suffering from X-linked chronic granulomatous disease (X-CGD), a rare inherited immunodeficiency characterized by recurrent, often life-threatening bacterial and fungal infections. Here we report on the molecular and cellular events observed in two young adults with X-CGD treated by gene therapy in 2004. After the initial resolution of bacterial and fungal infections, both subjects showed silencing of transgene expression due to methylation of the viral promoter, and myelodysplasia with monosomy 7 as a result of insertional activation of ecotropic viral integration site 1 (EVI1). One subject died from overwhelming sepsis 27 months after gene therapy, whereas a second subject underwent an allogeneic HSC transplantation. Our data show that forced overexpression of EVI1 in human cells disrupts normal centrosome duplication, linking EVI1 activation to the development of genomic instability, monosomy 7 and clonal progression toward myelodysplasia.